2020-2027 Analysis and Review Plasminogen Market

Plasminogen Market

Plasminogen Market By Application (Thrombosis, Ligneous Conjunctivitis, Ischemic Heart Disease and Others), By End Users (Hospital & Clinics, Ambulatory Surgical Centers and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

06-05-2020 REP-HC-5076 40 Tables 120 pages Format

The plasminogen market was valued at USD 1,407.1 Mn by 2019. Significant increase in the number of people suffering from deep vein thrombosis worldwide primarily drives the plasminogen market growth. Additionally, the constant rise in the number of people suffering from ischemic heart disease throughout the globe will further boost the plasminogen market growth.

 Plasminogen Market

Plasminogen is the zymogen form of plasmin which is released by the liver in the systemic blood circulation. There are 2 glycoforms of plasminogen present in the human body, it is classified as a serine protease having a molecular weight of 92.000 daltons and its structure comprises of 791 amino acids.

The major segments related to the plasminogen market are: 

By Application (2017–2027; US$ Mn)

Thrombosis

Ligneous Conjunctivitis

Ischemic Heart Disease

Others

By End Users (2017–2027; US$ Mn)

Hospital & Clinics

Ambulatory Surgical Centers

Others

Geography Segment (2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global plasminogen market
  • The overall segmentation of the plasminogen market, by application, end-users, and geography is minutely studied. Thrombosis and hospital & clinics are dominating the application and end-user segments respectively
  • A constant rise in the number of patients suffering from deep vein thrombosis/pulmonary embolism worldwide
  • Progressive research conducted on the therapeutic application of plasminogen in the treatment of ligneous conjunctivitis further propel the market growth

Report gist?

  • The study of the global plasminogen market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of application and end-users and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the biopharmaceutical companies actively engaged in the production and marketing of Plasminogen due to the rising prevalence of deep vein thrombosis worldwide
  • The report will benefit researcher engaged in the drug formulation of plasminogen in the treatment of ischemic heart disease
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to plasminogen market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies. 

Segment Analysis

Thrombosis is presently representing the largest market share in the application segment for the plasminogen market. The major forms of thrombosis encountered in human beings are deep vein thrombosis, pulmonary embolism, and venous thromboembolism. These diseases are of grievous nature and if not treated immediately will eventually result in the death of the ailing patient. As per the recent research findings provided by the World Thrombosis Day report, each year there are approximately 10 million cases of venous thromboembolism reported worldwide. Ischemic heart disease will be registering comfortable market growth in the near future on account of the significant increase in unhealthy lifestyle, diet, stress, and high consumption of tobacco and alcohol throughout the globe. According to the statistics provided by the World Health Organization (WHO), approximately 9 million deaths are recorded worldwide each year related to ischemic heart disease. 

Hospitals and clinics are spearheading the end-user segment for the plasminogen market. The chief attributes associated with its supreme market growth is the significant increase in the inpatient admission in the intensive care units for the treatment of ischemic heart diseases worldwide. Ambulatory surgical centers have gained strong ground in the last 2 decades owing to its ability to provide emergency medical assistance to patients suffering from deep vein thrombosis in remote locations. 

North America is currently leading the geography segment for the plasminogen market. The key parameter driving its market growth is the rising prevalence of ischemic heart disease in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC) it is estimated that approximately after every 40 seconds an American suffers from myocardial infarction. Furthermore domicile of major players such as Genentech, Inc. (Roche), Boehringer Ingelheim, Bayer AG, Merck & Co. further propel the market growth in the region. Europe is considered as the 2nd largest regional segment in the plasminogen market owing to the rising prevalence of thrombosis in the region. As per the latest research citings presented by the European Commission report, annually it is estimated that 370,012 deaths related to venous thromboembolism occurs in the region. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period owing to the developing healthcare infrastructure and constant rise in the medical tourism industry in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.